Assuntos
Terapia de Luz Pulsada Intensa , Dermatopatias Vasculares/terapia , Telangiectasia/terapia , Idoso , Feminino , Humanos , Satisfação do Paciente , Índice de Gravidade de Doença , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/patologia , Telangiectasia/diagnóstico , Telangiectasia/patologia , Resultado do TratamentoAssuntos
Neoplasias de Cabeça e Pescoço/diagnóstico , Meningioma/diagnóstico , Couro Cabeludo/patologia , Neoplasias Cutâneas/diagnóstico , Adulto , Feminino , Neoplasias de Cabeça e Pescoço/patologia , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Meningioma/patologia , Meningioma/cirurgia , Couro Cabeludo/cirurgia , Pele/patologia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgiaRESUMO
A 49-year old woman was hospitalized for generalized rash and pruritus following the administration of ophthalmic drops containing ciprofloxacin to treat conjunctivitis. Physical examination demonstrated diffuse erythematous papules and plaques with a targetoid appearance, injected sclera, and multiple erosions in the oropharynx. Skin biopsy confirmed a diagnosis of erythema multiforme major. The eye drops were discontinued and supportive treatment was initiated; the patient recovered in four weeks and was discharged from the hospital. Although cases such as this are rare, it is important that physicians take a thorough medication history from all patients with suspected erythema multiforme, including topical and ophthalmic medications. Prompt discontinuation of the offending agent can hasten patient recovery and optimize outcomes.
